StockData
Upstream Bio, Inc. logo

Upstream Bio, Inc. (UPB) income statement

UPBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$1.59−0.41 (-20.50%)

Close on Nov 20, 2026Market cap $87.09MP/E –Yield –

See a number that looks wrong?